Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Crystalluria and urinary tract abnormalities associated with indinavir.

Kopp JB, Miller KD, Mican JA, Feuerstein IM, Vaughan E, Baker C, Pannell LK, Falloon J.

Ann Intern Med. 1997 Jul 15;127(2):119-25.

PMID:
9230000
2.

Changes in renal function associated with indinavir.

Boubaker K, Sudre P, Bally F, Vogel G, Meuwly JY, Glauser MP, Telenti A.

AIDS. 1998 Dec 24;12(18):F249-54.

PMID:
9875572
3.

Acute tubulointerstitial nephritis attributable to indinavir therapy.

Jaradat M, Phillips C, Yum MN, Cushing H, Moe S.

Am J Kidney Dis. 2000 Apr;35(4):E16.

PMID:
10739809
4.

Crystalluria and urinary tract abnormalities associated with indinavir.

Clayman RV.

J Urol. 1998 Aug;160(2):633. No abstract available.

PMID:
9679944
5.

Indinavir crystalluria: identification of patients at increased risk of developing nephrotoxicity.

Trainor LD, Steinberg JP, Austin GW, Solomon HM.

Arch Pathol Lab Med. 1998 Mar;122(3):256-9.

PMID:
9823864
6.

Pyuria in patients treated with indinavir is associated with renal dysfunction.

Sarcletti M, Petter A, Romani N, Lhotta K, König P, Maier H, Zangerle R.

Clin Nephrol. 2000 Oct;54(4):261-70.

PMID:
11076101
7.

Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir.

Gagnon RF, Tecimer SN, Watters AK, Tsoukas CM.

Am J Kidney Dis. 2000 Sep;36(3):507-15.

PMID:
10977782
8.

Risk factors for urological symptoms in a cohort of users of the HIV protease inhibitor indinavir sulfate: the ATHENA cohort.

Dieleman JP, Sturkenboom MC, Jambroes M, Gyssens IC, Weverling GJ, ten Veen JH, Schrey G, Reiss P, Stricker BH; Athena Study Group.

Arch Intern Med. 2002 Jul 8;162(13):1493-501.

PMID:
12090886
9.

Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients.

Dieleman JP, Gyssens IC, van der Ende ME, de Marie S, Burger DM.

AIDS. 1999 Mar 11;13(4):473-8.

PMID:
10197375
10.

Symptomatic crystalluria associated with indinavir.

Famularo G, Di Toro S, Moretti S, De Simone C.

Ann Pharmacother. 2000 Dec;34(12):1414-8. Review.

PMID:
11144699
11.

Protease inhibitor-induced urolithiasis.

Gentle DL, Stoller ML, Jarrett TW, Ward JF, Geib KS, Wood AF.

Urology. 1997 Oct;50(4):508-11.

PMID:
9338723
12.

Low urine pH is associated with reduced indinavir crystalluria in indinavir-treated HIV-infected individuals.

Gagnon RF, Alli AI, Edwardes MD, Watters AK, Tsoukas CM.

Clin Nephrol. 2006 Jan;65(1):13-21.

PMID:
16429837
13.

Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavir.

Dieleman JP, van Rossum AM, Stricker BC, Sturkenboom MC, de Groot R, Telgt D, Blok WL, Burger DM, Blijenberg BG, Zietse R, Gyssens IC.

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):135-42.

PMID:
12571522
14.

[Indinavir-associated tubulointerstitial renal disease].

Gagnon RF, Mehio A, Iqbal S, Tsoukas CM.

Nephrol Ther. 2007 Dec;3(7):461-2. Epub 2007 Sep 18. French.

PMID:
18048001
15.

Effects of escin on indinavir crystallization time in the urine of patients with HIV-I infection: a multicenter, randomized, open-label, controlled, four-period crossover trial.

Grases F, García-González R, Redondo E, Costa-Bauzá A, Simonet BM, Sartini RP, Bassa A, Gallegos C, Payeras A, Saro D, Martinez AI, Cifuentes C, Homar F, Murillo JA, Fernández C, Riera M, Conte A.

Clin Ther. 2004 Dec;26(12):2045-55.

PMID:
15823768
16.

Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients.

Brodie SB, Keller MJ, Ewenstein BM, Sax PE.

AIDS. 1998 Dec 24;12(18):2433-7.

PMID:
9875581
17.

High prevalence of indinavir-associated renal complications in Thai HIV-infected patients.

Avihingsanon A, Avihingsanon Y, Darnpornprasert P, Kerr S, Ungsedhapand C, Duncombe C, Ubolyam S, Ruxrungtham K, Phanuphak P.

J Med Assoc Thai. 2006 Aug;89 Suppl 2:S21-7.

PMID:
17044450
18.

Urolithiasis associated with the protease inhibitor indinavir.

Bruce RG, Munch LC, Hoven AD, Jerauld RS, Greenburg R, Porter WH, Rutter PW.

Urology. 1997 Oct;50(4):513-8.

PMID:
9338724
19.

[Crystalluria and nephrolithiasis during therapy with the protease inhibitor indinavir].

Rickerts V, Kober A, Stille W.

Dtsch Med Wochenschr. 1997 Jun 13;122(24):803. German. No abstract available.

PMID:
9229567
20.

Treatment for human immunodeficiency virus with indinavir may cause relevant urological side-effects, effectively treatable by rehydration.

Hug B, Naef M, Bucher HC, Sponagel L, Lehmann K, Battegay M.

BJU Int. 1999 Oct;84(6):610-4.

PMID:
10510102

Supplemental Content

Support Center